Table: Fuji Pharmaceutical -2019/20 parent results

Fuji Pharma

05/11/2020 07:30

Nov 5 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to      NEXT     
              Sep 30, 2020    Sep 30, 2019   Sep 30, 2021     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           31.26           33.74          32.82         16.43    
               (-7.3 pct)      (-4.8 pct)     (+5.0 pct)    (+5.2 pct)  
  Operating        2.90            3.85           3.00          1.79    
               (-24.5 pct)     (-5.1 pct)     (+3.4 pct)    (+21.4 pct) 
  Recurring        2.81            3.97           2.95          1.76    
               (-29.2 pct)     (-6.3 pct)     (+5.1 pct)    (+27.2 pct) 
  Net              2.02            2.84           2.27          1.41    
               (-29.1 pct)     (-12.1 pct)    (+12.5 pct)  (+612.5 pct) 
  EPS           64.70 yen       93.10 yen      72.76 yen     45.16 yen  
  Ann Div       29.00 yen       29.00 yen      29.00 yen                
  -Q2 Div       14.00 yen       14.00 yen      14.00 yen                
  -Q4 Div       15.00 yen       15.00 yen      15.00 yen                
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T